Biosynthesis, Deficiency, and Supplementation of Coenzyme Q

Originally identified as a key component of the mitochondrial respiratory chain, Coenzyme Q (CoQ or CoQ10 for human tissues) has recently been revealed to be essential for many different redox processes, not only in the mitochondria, but elsewhere within other cellular membrane types. Cells rely on endogenous CoQ biosynthesis, and defects in this still-not-completely understood pathway result in primary CoQ deficiencies, a group of conditions biochemically characterised by decreased tissue CoQ levels, which in turn are linked to functional defects. Secondary CoQ deficiencies may result from a wide variety of cellular dysfunctions not directly linked to primary synthesis. In this article, we review the current knowledge on CoQ biosynthesis, the defects leading to diminished CoQ10 levels in human tissues and their associated clinical manifestations.

[1]  E. Bonora,et al.  Mutant SPART causes defects in mitochondrial protein import and bioenergetics reversed by Coenzyme Q , 2023, Open Biology.

[2]  G. López-Lluch,et al.  Coenzyme Q10 Metabolism: A Review of Unresolved Issues , 2023, International journal of molecular sciences.

[3]  T. Langer,et al.  Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7 , 2023, Nature Cell Biology.

[4]  D. Pagliarini,et al.  Coenzyme Q biochemistry and biosynthesis. , 2023, Trends in biochemical sciences.

[5]  I. Hargreaves,et al.  Depletion and Supplementation of Coenzyme Q10 in Secondary Deficiency Disorders. , 2022, Frontiers in bioscience.

[6]  E. Emekli-Alturfan,et al.  The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence , 2022, Molecular Biology Reports.

[7]  D. Timmann,et al.  Bi‐Allelic COQ4 Variants Cause Adult‐Onset Ataxia‐Spasticity Spectrum Disease , 2022, Movement disorders : official journal of the Movement Disorder Society.

[8]  A. Heck,et al.  The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency , 2022, Redox biology.

[9]  P. Meikle,et al.  High-intensity training induces non-stoichiometric changes in the mitochondrial proteome of human skeletal muscle without reorganisation of respiratory chain content , 2021, Nature Communications.

[10]  J. Coon,et al.  Structure and functionality of a multimeric human COQ7:COQ9 complex , 2021, bioRxiv.

[11]  G. Vasco,et al.  Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypes , 2021, Journal of Medical Genetics.

[12]  Robert S. Banh,et al.  The polar oxy-metabolome reveals the 4-hydroxymandelate CoQ10 synthesis pathway , 2021, Nature.

[13]  J. Kallijärvi,et al.  The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology , 2021, The FEBS journal.

[14]  C. Clarke,et al.  Coenzyme Q Biosynthesis: An Update on the Origins of the Benzenoid Ring and Discovery of New Ring Precursors , 2021, Metabolites.

[15]  G. López-Lluch,et al.  Secondary CoQ10 deficiency, bioenergetics unbalance in disease and aging , 2021, BioFactors.

[16]  A. Tessa,et al.  New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ10 deficiency in muscle or skin fibroblasts , 2021, Journal of Neurology.

[17]  E. Trevisson,et al.  Primary coenzyme Q deficiencies: A literature review and online platform of clinical features to uncover genotype-phenotype correlations. , 2021, Free radical biology & medicine.

[18]  G. Lenaers,et al.  Secondary coenzyme q deficiency in neurological disorders. , 2021, Free radical biology & medicine.

[19]  V. Carelli,et al.  Missense PDSS1 mutations in CoenzymeQ10 synthesis cause optic atrophy and sensorineural deafness , 2020, Annals of clinical and translational neurology.

[20]  Timothy E. Yap,et al.  Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain , 2020, International journal of molecular sciences.

[21]  S. Heales,et al.  CoQ10 Deficient Endothelial Cell Culture Model for the Investigation of CoQ10 Blood–Brain Barrier Transport , 2020, Journal of clinical medicine.

[22]  I. Hargreaves,et al.  Disorders of Human Coenzyme Q10 Metabolism: An Overview , 2020, International journal of molecular sciences.

[23]  M. Mroczek,et al.  Adult‐onset very‐long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) , 2020, European journal of neurology.

[24]  E. Bouveret,et al.  The O2-independent pathway of ubiquinone biosynthesis is essential for denitrification in Pseudomonas aeruginosa , 2020, The Journal of Biological Chemistry.

[25]  Min Goo Lee,et al.  ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment. , 2020, Journal of the American Society of Nephrology : JASN.

[26]  C. Quinzii,et al.  Redefining infantile-onset multisystem phenotypes of coenzyme Q10-deficiency in the next-generation sequencing era , 2020, Journal of translational genetics and genomics.

[27]  J. Hicks,et al.  An in situ atlas of mitochondrial DNA in mammalian tissues reveals high content in stem/progenitor cells. , 2020, The American journal of pathology.

[28]  O. Shirihai,et al.  COQ11 deletion mitigates respiratory deficiency caused by mutations in the gene encoding the coenzyme Q chaperone protein Coq10 , 2020, The Journal of Biological Chemistry.

[29]  H. Yen,et al.  Characterization of human mitochondrial PDSS and COQ proteins and their roles in maintaining coenzyme Q10 levels and each other's stability. , 2020, Biochimica et biophysica acta. Bioenergetics.

[30]  A. Olgaç,et al.  A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[31]  S. Hekimi,et al.  The Complexity of Making Ubiquinone , 2019, Trends in Endocrinology & Metabolism.

[32]  J. Olzmann,et al.  The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis , 2019, Nature.

[33]  A. Konnerth,et al.  Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity , 2019, Nature Neuroscience.

[34]  P. Navas,et al.  Vanillic Acid Restores Coenzyme Q Biosynthesis and ATP Production in Human Cells Lacking COQ6 , 2019, Oxidative medicine and cellular longevity.

[35]  M. Fontecave,et al.  Ubiquinone Biosynthesis over the Entire O2 Range: Characterization of a Conserved O2-Independent Pathway , 2019, mBio.

[36]  Jun Z. Li,et al.  COQ4 Mutation Leads to Childhood-Onset Ataxia Improved by CoQ10 Administration , 2019, The Cerebellum.

[37]  M. Gallagher-Jones,et al.  Human COQ10A and COQ10B are distinct lipid-binding START domain proteins required for coenzyme Q function[S] , 2019, Journal of Lipid Research.

[38]  M. Fontecave,et al.  A Soluble Metabolon Synthesizes the Isoprenoid Lipid Ubiquinone. , 2019, Cell chemical biology.

[39]  L. Ulatowski,et al.  Vitamin E: Mechanism of transport and regulation in the CNS , 2019, IUBMB life.

[40]  F. Hildebrandt,et al.  Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice. , 2019, Journal of the American Society of Nephrology : JASN.

[41]  J. Coon,et al.  Coenzyme Q biosynthetic proteins assemble in a substrate-dependent manner into domains at ER–mitochondria contacts , 2019, The Journal of cell biology.

[42]  M. Schuldiner,et al.  The Endoplasmic Reticulum-Mitochondria Encounter Structure Complex Coordinates Coenzyme Q Biosynthesis , 2019, Contact (Thousand Oaks (Ventura County, Calif.)).

[43]  J. Duarte,et al.  β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9 R239X mice , 2018, EMBO molecular medicine.

[44]  R. Peters,et al.  Isoprenyl diphosphate synthases: the chain length determining step in terpene biosynthesis , 2018, Planta.

[45]  A. Mégarbané,et al.  COQ8A and MED25 Mutations in a Child with Intellectual Disability, Microcephaly, Seizures, and Spastic Ataxia: Synergistic Effect of Digenic Variants , 2018, Molecular Syndromology.

[46]  M. Donnino,et al.  Coenzyme Q10 in acute influenza , 2018, Influenza and other respiratory viruses.

[47]  R. Rodenburg,et al.  Coenzyme Q10 deficiency due to a COQ4 gene defect causes childhood-onset spinocerebellar ataxia and stroke-like episodes , 2018, Molecular genetics and metabolism reports.

[48]  E. Trevisson,et al.  Clinical syndromes associated with Coenzyme Q10 deficiency. , 2018, Essays in biochemistry.

[49]  C. Clarke,et al.  Coenzyme Q10 deficiencies: pathways in yeast and humans , 2018, Essays in biochemistry.

[50]  Carol E Smith,et al.  Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose , 2018, BMC Cardiovascular Disorders.

[51]  Kitti Brinyiczki,et al.  Diffuse mesangial sclerosis in a PDSS2 mutation-induced coenzyme Q10 deficiency , 2018, Pediatric Nephrology.

[52]  Sean J. Humphrey,et al.  Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance , 2018, eLife.

[53]  Robert W. Taylor,et al.  A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C‐methyltransferase deficiency , 2018, Human mutation.

[54]  Christopher P. Lapointe,et al.  Multi-omics Reveal Specific Targets of the RNA-Binding Protein Puf3p and Its Orchestration of Mitochondrial Biogenesis. , 2017, Cell systems.

[55]  Nicholas W. Kwiecien,et al.  Multi-omic mitoprotease profiling defines a role for Oct1p in coenzyme Q production , 2017, bioRxiv.

[56]  L. C. López,et al.  Bypassing human CoQ10 deficiency. , 2017, Molecular genetics and metabolism.

[57]  Paul D Hutchins,et al.  Conserved Lipid and Small-Molecule Modulation of COQ8 Reveals Regulation of the Ancient Kinase-like UbiB Family. , 2017, Cell chemical biology.

[58]  I. Atanassov,et al.  Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals , 2017, eLife.

[59]  F. Wang,et al.  Steroid-resistant nephrotic syndrome caused by co-inheritance of mutations at NPHS1 and ADCK4 genes in two Chinese siblings. , 2017, Intractable & rare diseases research.

[60]  R. Rodenburg,et al.  4‐Hydroxybenzoic acid restores CoQ10 biosynthesis in human COQ2 deficiency , 2017, Annals of clinical and translational neurology.

[61]  D. Pagliarini,et al.  Biochemistry of Mitochondrial Coenzyme Q Biosynthesis. , 2017, Trends in biochemical sciences.

[62]  R. de Cabo,et al.  Kaempferol increases levels of coenzyme Q in kidney cells and serves as a biosynthetic ring precursor , 2017, Free radical biology & medicine.

[63]  M. Accetturo,et al.  Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants , 2017, Clinical genetics.

[64]  K. Moon,et al.  COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[65]  F. Pierrel Impact of Chemical Analogs of 4-Hydroxybenzoic Acid on Coenzyme Q Biosynthesis: From Inhibition to Bypass of Coenzyme Q Deficiency , 2017, Front. Physiol..

[66]  N. Sondheimer,et al.  Novel recessive mutations in COQ4 cause severe infantile cardiomyopathy and encephalopathy associated with CoQ10 deficiency , 2017, Molecular genetics and metabolism reports.

[67]  Aneal Khan,et al.  Pathogenicity of two COQ7 mutations and responses to 2,4‐dihydroxybenzoate bypass treatment , 2017, Journal of cellular and molecular medicine.

[68]  A. Elmacı,et al.  Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment , 2017, Pediatric Nephrology.

[69]  J. Sánchez-Alcázar,et al.  Amitriptyline down‐regulates coenzyme Q10 biosynthesis in lung cancer cells , 2017, European journal of pharmacology.

[70]  Nicola Zamboni,et al.  An integrative metabolomics and transcriptomics study to identify metabolic alterations in aged skin of humans in vivo , 2017, BMC Genomics.

[71]  D. Torres-Russotto,et al.  A novel CABC1/ADCK3 mutation in adult-onset cerebellar ataxia. , 2016, Parkinsonism & related disorders.

[72]  P. Navas,et al.  Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders. , 2016, Mitochondrion.

[73]  D. Schneider,et al.  Evolution of Ubiquinone Biosynthesis: Multiple Proteobacterial Enzymes with Various Regioselectivities To Catalyze Three Contiguous Aromatic Hydroxylation Reactions , 2016, mSystems.

[74]  S. Johansson,et al.  ADCK3 mutations with epilepsy, stroke‐like episodes and ataxia: a POLG mimic? , 2016, European journal of neurology.

[75]  M. Moscovich,et al.  Statin-associated cerebellar ataxia. A Brazilian case series. , 2016, Parkinsonism & related disorders.

[76]  M. Kawamukai Biosynthesis of coenzyme Q in eukaryotes , 2016, Bioscience, biotechnology, and biochemistry.

[77]  S. Crovella,et al.  Alendronate, a double-edged sword acting in the mevalonate pathway , 2015, Molecular medicine reports.

[78]  T. Meitinger,et al.  Fatal neonatal encephalopathy and lactic acidosis caused by a homozygous loss-of-function variant in COQ9 , 2015, European Journal of Human Genetics.

[79]  A. Mourier,et al.  Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4–dihydroxybensoic acid , 2015, Journal of Medical Genetics.

[80]  D. Acuña-Castroviejo,et al.  The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene , 2015, EMBO molecular medicine.

[81]  S. Hekimi,et al.  Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis , 2015, Nature Communications.

[82]  E. Bertini,et al.  COQ4 Mutations Cause a Broad Spectrum of Mitochondrial Disorders Associated with CoQ10 Deficiency , 2015, American journal of human genetics.

[83]  Crysten E. Blaby-Haas,et al.  Identification of Coq11, a New Coenzyme Q Biosynthetic Protein in the CoQ-Synthome in Saccharomyces cerevisiae* , 2015, The Journal of Biological Chemistry.

[84]  E. Trevisson,et al.  Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10) deficiency , 2015, Journal of Inherited Metabolic Disease.

[85]  Yuki Ogiyama,et al.  Functional Conservation of Coenzyme Q Biosynthetic Genes among Yeasts, Plants, and Humans , 2014, PloS one.

[86]  Christian G Elowsky,et al.  The Origin and Biosynthesis of the Benzenoid Moiety of Ubiquinone (Coenzyme Q) in Arabidopsis[W] , 2014, Plant Cell.

[87]  Stephanie D. Wilson,et al.  A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. , 2014, JAMA neurology.

[88]  I. Hargreaves Coenzyme Q10 as a therapy for mitochondrial disease. , 2014, The international journal of biochemistry & cell biology.

[89]  M. Sikorska,et al.  Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease , 2014, BMC Neuroscience.

[90]  G. Rimbach,et al.  Nitrogen-bisphosphonate therapy is linked to compromised coenzyme Q10 and vitamin E status in postmenopausal women. , 2014, The Journal of clinical endocrinology and metabolism.

[91]  P. Navas,et al.  Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency☆ , 2014, Biochimica et biophysica acta.

[92]  S. Seneca,et al.  Characterization of CoQ10 biosynthesis in fibroblasts of patients with primary and secondary CoQ10 deficiency , 2014, Journal of Inherited Metabolic Disease.

[93]  V. Plagnol,et al.  Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[94]  S. Seneca,et al.  Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[95]  R. Artuch,et al.  Coenzyme Q₁₀ deficiency in mitochondrial DNA depletion syndromes. , 2013, Mitochondrion.

[96]  N. Gregersen,et al.  Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple Acyl-CoA dehydrogenation deficiency. , 2013, Human molecular genetics.

[97]  Stefan Siebrecht,et al.  Ubiquinol supplementation enhances peak power production in trained athletes: a double-blind, placebo controlled study , 2013, Journal of the International Society of Sports Nutrition.

[98]  D. Stainier,et al.  Ubiad1 Is an Antioxidant Enzyme that Regulates eNOS Activity by CoQ10 Synthesis , 2013, Cell.

[99]  F. Rosenfeldt,et al.  Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial , 2013, Cardiology journal.

[100]  S. Rahman,et al.  Human neuronal coenzyme Q10 deficiency results in global loss of mitochondrial respiratory chain activity, increased mitochondrial oxidative stress and reversal of ATP synthase activity: implications for pathogenesis and treatment , 2013, Journal of Inherited Metabolic Disease.

[101]  S. Kelekçi,et al.  The relationships between clinical outcome and the levels of total antioxidant capacity (TAC) and coenzyme Q (CoQ 10) in children with pandemic influenza (H 1 N1) and seasonal flu. , 2012, European review for medical and pharmacological sciences.

[102]  S. Dimauro,et al.  Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. , 2012, Archives of neurology.

[103]  M. Fontecave,et al.  Overexpression of the Coq8 Kinase in Saccharomyces cerevisiae coq Null Mutants Allows for Accumulation of Diagnostic Intermediates of the Coenzyme Q6 Biosynthetic Pathway* , 2012, The Journal of Biological Chemistry.

[104]  M. Cordero,et al.  Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients. , 2012, Journal of psychiatric research.

[105]  D. Selkoe,et al.  Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. , 2011, Archives of neurology.

[106]  S. Dimauro,et al.  Coenzyme Q deficiency in muscle. , 2011, Current opinion in neurology.

[107]  M. Fontecave,et al.  Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation reaction and substrate analogs rescue Coq6 deficiency. , 2011, Chemistry & biology.

[108]  I. Carrié,et al.  Lifelong low-phylloquinone intake is associated with cognitive impairments in old rats. , 2011, The Journal of nutrition.

[109]  N. Pfanner,et al.  Mitochondrial protein turnover: role of the precursor intermediate peptidase Oct1 in protein stabilization , 2011, Molecular biology of the cell.

[110]  V. Pertegato,et al.  COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. , 2011, The Journal of clinical investigation.

[111]  W. Pavan,et al.  Oxidative stress in Niemann-Pick disease, type C. , 2010, Molecular genetics and metabolism.

[112]  M. Mikhail,et al.  Effects of Oral, Vaginal, and Transdermal Hormonal Contraception on Serum Levels of Coenzyme Q10, Vitamin E, and Total Antioxidant Activity , 2010, Obstetrics and gynecology international.

[113]  T. Douki,et al.  Involvement of mitochondrial ferredoxin and para-aminobenzoic acid in yeast coenzyme Q biosynthesis. , 2010, Chemistry & biology.

[114]  J. Berner Statins can produce ataxia in bipolar disorder: two case reports. , 2010, The Journal of clinical psychiatry.

[115]  M. Mancuso,et al.  Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy , 2010, Neuromuscular Disorders.

[116]  A. Verméglio,et al.  Menaquinone as pool quinone in a purple bacterium , 2009, Proceedings of the National Academy of Sciences.

[117]  A. Singleton,et al.  A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. , 2009, American journal of human genetics.

[118]  P. Sleiman,et al.  The coenzyme Q10 status of the brain regions of Parkinson’s disease patients , 2008, Neuroscience Letters.

[119]  L. Salviati,et al.  Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. , 2008, The New England journal of medicine.

[120]  A. Munnich,et al.  CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. , 2008, American journal of human genetics.

[121]  E. Bertini,et al.  COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. , 2007, Journal of the American Society of Nephrology : JASN.

[122]  H. Cavé,et al.  Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency , 2007, Journal of Inherited Metabolic Disease.

[123]  S. Dimauro,et al.  The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. , 2007, Brain : a journal of neurology.

[124]  A. Munnich,et al.  Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. , 2007, The Journal of clinical investigation.

[125]  Wayne R Matson,et al.  Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. , 2006, Biochimica et biophysica acta.

[126]  M. Mikhail,et al.  Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. , 2006, American journal of obstetrics and gynecology.

[127]  T. Lehtimäki,et al.  High‐dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial , 2005, Clinical pharmacology and therapeutics.

[128]  V. Mootha,et al.  Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation , 2005, Neurology.

[129]  G. López-Lluch,et al.  Specificity of coenzyme Q10 for a balanced function of respiratory chain and endogenous ubiquinone biosynthesis in human cells. , 2005, Biochimica et biophysica acta.

[130]  K. Yazaki,et al.  The AtPPT1 gene encoding 4-hydroxybenzoate polyprenyl diphosphate transferase in ubiquinone biosynthesis is required for embryo development in Arabidopsis thaliana , 2004, Plant Molecular Biology.

[131]  S. Dimauro,et al.  Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. , 2004, Archives of neurology.

[132]  I. Hargreaves Ubiquinone: cholesterol's reclusive cousin , 2003, Annals of clinical biochemistry.

[133]  T. Chojnacki,et al.  Distribution and breakdown of labeled coenzyme Q10 in rat. , 2003, Free radical biology & medicine.

[134]  Anil K. Goli,et al.  Simvastatin‐induced lactic acidosis: A rare adverse reaction? , 2002, Clinical pharmacology and therapeutics.

[135]  Joel S Perlmutter,et al.  Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. , 2002, Archives of neurology.

[136]  S. Passi,et al.  Lipophilic Antioxidants in Human Sebum and Aging , 2002, Free radical research.

[137]  M. Kawamukai,et al.  Dimer Formation of Octaprenyl-diphosphate Synthase (IspB) Is Essential for Chain Length Determination of Ubiquinone* , 2001, The Journal of Biological Chemistry.

[138]  R. Floyd Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[139]  S. Browne,et al.  Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[140]  B. Angelin,et al.  Gemfibrozil‐induced decrease in serum ubiquinone and α‐ and γ‐tocopherol levels in men with combined hyperlipidaemia , 1998 .

[141]  M. Beal,et al.  Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects , 1997, Annals of neurology.

[142]  C. Clarke,et al.  A C-methyltransferase involved in both ubiquinone and menaquinone biosynthesis: isolation and identification of the Escherichia coli ubiE gene , 1997, Journal of bacteriology.

[143]  Y. Kamiya,et al.  Polyprenyl diphosphate synthase essentially defines the length of the side chain of ubiquinone. , 1996, Biochimica et biophysica acta.

[144]  R. E. Beyer The role of ascorbate in antioxidant protection of biomembranes: Interaction with vitamin E and coenzyme Q , 1994, Journal of bioenergetics and biomembranes.

[145]  I. Nonaka,et al.  Muscle coenzyme Q10 in mitochondrial encephalomyopathies , 1991, Neuromuscular Disorders.

[146]  B. Ames,et al.  Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[147]  K. Kristensson,et al.  Lipid Compositions of Different Regions of the Human Brain During Aging , 1990, Journal of neurochemistry.

[148]  G. Dallner,et al.  Age-related changes in the lipid compositions of rat and human tissues , 1989, Lipids.

[149]  K. Folkers,et al.  Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[150]  G. Cox,et al.  Biosynthesis of Ubiquinone in Escherichia coli K-12: Biochemical and Genetic Characterization of a Mutant Unable to Convert Chorismate into 4-Hydroxybenzoate , 1974, Journal of bacteriology.

[151]  P. Palacka,et al.  Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19. , 2022, Bratislavske lekarske listy.

[152]  F. Rosenfeldt,et al.  Statin-Associated Cardiomyopathy Responds to Statin Withdrawal and Administration of Coenzyme Q10. , 2019, The Permanente journal.

[153]  O. Gribouval,et al.  ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS. , 2016, Journal of the American Society of Nephrology : JASN.

[154]  Anne-Lise Ducluzeau,et al.  Gene network reconstruction identifies the authentic trans-prenyl diphosphate synthase that makes the solanesyl moiety of ubiquinone-9 in Arabidopsis. , 2012, The Plant journal : for cell and molecular biology.

[155]  C. Clarke,et al.  The yeast Coq4 polypeptide organizes a mitochondrial protein complex essential for coenzyme Q biosynthesis. , 2009, Biochimica et biophysica acta.

[156]  S. Heales,et al.  The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q10 , 2005, Drug safety.

[157]  Kathleen Connell,et al.  Effects of menopause and hormone replacement therapy on serum levels of coenzyme Q10 and other lipid‐soluble antioxidants , 2005, BioFactors.

[158]  S. Dimauro,et al.  Primary coenzyme Q10 deficiency and the brain , 2003, BioFactors.

[159]  J. Bergemann,et al.  Coenzyme Q10, a cutaneous antioxidant and energizer , 1999, BioFactors.

[160]  F. L. Crane,et al.  Isolation of a quinone from beef heart mitochondria. , 1957, Biochimica et biophysica acta.